Skip to Content
Merck

MAB4410

Anti-Renilla Luciferase Antibody, clone 1D5.2

ascites fluid, clone 1D5.2, Chemicon®

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Clone:
1D5.2, monoclonal
Technique(s):
ELISA: suitable, western blot: suitable
Application:
ELISA, WB
Citations:
16
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


biological source

mouse

antibody form

ascites fluid

antibody product type

primary antibodies

clone

1D5.2, monoclonal

species reactivity (predicted by homology)

all

manufacturer/tradename

Chemicon®

technique(s)

ELISA: suitable, western blot: suitable

isotype

IgG

UniProt accession no.

shipped in

dry ice

target post-translational modification

unmodified

General description

36 kDa

Immunogen

Renilla luciferase GST fusion protein.

Application

Immunoblotting

EIA

Optimal working dilutions must be determined by end user.
Research Category
Epitope Tags & General Use
Research Sub Category
Epitope Tags
This Anti-Renilla Luciferase Antibody, clone 1D5.2 is validated for use in ELISA, WB for the detection of Renilla Luciferase.

Biochem/physiol Actions

Recognizes Renilla luciferase.

Physical form

Liquid.
Unpurified

Preparation Note

Maintain for 1 year at -20°C from date of shipment. Aliquot to avoid repeated freezing and thawing. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Analysis Note

Control
Renilla

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.


Still not finding the right product?

Try our Product Selector Tool to narrow your options


Storage Class

10 - Combustible liquids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable



Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Hans H Schiffer et al.
Molecular pharmacology, 71(2), 508-518 (2006-09-14)
We have developed a new assay for measuring epidermal growth factor receptor (EGFR) activation using the bioluminescence resonance energy transfer (BRET) technology, which directly measures the recruitment of signaling proteins to activated EGFR. Our results demonstrate that EGFR BRET assays
Ruth Röck et al.
Scientific reports, 5, 11133-11133 (2015-06-24)
Membrane receptor-sensed input signals affect and modulate intracellular protein-protein interactions (PPIs). Consequent changes occur to the compositions of protein complexes, protein localization and intermolecular binding affinities. Alterations of compartmentalized PPIs emanating from certain deregulated kinases are implicated in the manifestation
Johanna E Mayrhofer et al.
Proceedings of the National Academy of Sciences of the United States of America, 117(49), 31105-31113 (2020-11-25)
Kinase-targeted therapies have the potential to improve the survival of patients with cancer. However, the cancer-specific spectrum of kinase alterations exhibits distinct functional properties and requires mutation-oriented drug treatments. Besides post-translational modifications and diverse intermolecular interactions of kinases, it is